05/10/2026

SGH Medical Pharma, a French group specialising in medical devices and products, this week inaugurated its first industrial facility outside France in Mégrine, a suburb of Tunis, marking a new milestone in the development of its international operations and in the strengthening of Franco-Tunisian economic relations.
Covering an area of 3,000 m², this new industrial facility will boost the group’s production capacity and support its expansion into international markets. Based in Saint-Marcellin, in the Isère department, SGH Medical Pharma employs around 350 people, nearly 250 of whom are based in France.
This investment sends a strong signal of confidence from French investors in Tunisia’s industrial capabilities and expertise within the healthcare sector. It also illustrates the emergence of cooperation that is increasingly focused on production, moving upmarket and creating value.
Translated with DeepL.com (free version)
The new facility is expected to create nearly a hundred skilled jobs, particularly for young Tunisian professionals, and to produce high-precision medical devices that meet the requirements of European markets.
Beyond the investment itself, the project reinforces Tunisia’s position as a competitive industrial hub for the healthcare sector in North Africa, drawing on its geographical proximity to Europe, its human capital and its experience in industrial activities geared towards international markets.
The establishment of SGH Medical Pharma is therefore part of a broader drive to develop Franco-Tunisian value chains, in which the complementarity between French industrial know-how and Tunisian expertise can foster greater integration, technology transfer and access to international markets.
SGH Medical Pharma’s investment comes at a time when Tunisia is seeking to enhance its appeal to international investors in the industrial and technology sectors, particularly those offering prospects for moving upmarket, exports and skilled employment.